AltaThera Pharmaceuticals Names Dr. Jim Perry as Pediatric Chief Medical Officer
AltaThera Pharmaceuticals has named pediatric cardiac electrophysiologist Dr. Jim Perry as Pediatric Chief Medical Officer.
AltaThera Pharmaceuticals has named pediatric cardiac electrophysiologist Dr. Jim Perry as Pediatric Chief Medical Officer.
As part of a company retreat in Tampa, AltaThera donated $1,500 to the Humane Society of Tampa Bay.
In July 2025, the U.S. Food and Drug Administration approved a label expansion for Sotalol IV, adding a new indication for pediatric patients with life-threatening ventricular arrhythmias and for the maintenance of normal sinus rhythm in atrial fibrillation and atrial flutter. This approval reflects AltaThera’s ongoing commitment to expanding access to personalized antiarrhythmic therapy for patients of all ages.